PureTech Health plc (NASDAQ:PRTC – Get Free Report)’s stock price gapped down before the market opened on Thursday . The stock had previously closed at $28.51, but opened at $27.11. PureTech Health shares last traded at $28.68, with a volume of 3,025 shares traded.
PureTech Health Stock Performance
The firm’s 50-day simple moving average is $27.55 and its two-hundred day simple moving average is $24.46.
Institutional Investors Weigh In On PureTech Health
An institutional investor recently bought a new position in PureTech Health stock. AWM Investment Company Inc. purchased a new stake in shares of PureTech Health plc (NASDAQ:PRTC – Free Report) during the 1st quarter, according to the company in its most recent filing with the SEC. The fund purchased 6,900 shares of the company’s stock, valued at approximately $197,000. 0.04% of the stock is currently owned by institutional investors and hedge funds.
PureTech Health Company Profile
PureTech Health plc, a clinical stage biotherapeutics company, engages in the discovery, development, and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, currently under Phase 3 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, to inhibit the activity of galectin-9 for treating solid tumors and hematological malignancies.
Further Reading
- Five stocks we like better than PureTech Health
- What Makes a Stock a Good Dividend Stock?
- MarketBeat Week in Review – 5/13 – 5/17
- What is Short Interest? How to Use It
- Take-Two Interactive Software Offers 2nd Chance for Investors
- Market Cap Calculator: How to Calculate Market Cap
- Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
